HKSE:09877 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:09877 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2025-01-18), Jenscare Scientific Co's share price is HK$4.03. Jenscare Scientific Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.77. Hence, Jenscare Scientific Co's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Jenscare Scientific Co's Price-to-Free-Cash-Flow or its related term are showing as below:
Jenscare Scientific Co's Free Cash Flow per Share for the six months ended in Jun. 2024 was HK$-0.34. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was HK$-0.77.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -78.00% per year.
During the past 4 years, Jenscare Scientific Co's highest 3-Year average Free Cash Flow per Share Growth Rate was -78.00% per year. The lowest was -78.00% per year. And the median was -78.00% per year.
The historical data trend for Jenscare Scientific Co's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenscare Scientific Co Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Price-to-Free-Cash-Flow | - | - | - | - |
Jenscare Scientific Co Semi-Annual Data | ||||||||
Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Devices subindustry, Jenscare Scientific Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's Price-to-Free-Cash-Flow falls into.
Jenscare Scientific Co's Price-to-Free-Cash-Flow ratio for today is calculated as
Price-to-Free-Cash-Flow Ratio | = | Share Price | / | Free Cash Flow per Share (TTM) |
= | 4.03 | / | -0.773 | |
= | N/A |
Jenscare Scientific Co's Share Price of today is HK$4.03.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.77.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price-to-Free-Cash-Flow Ratio | = | Market Cap | / | Free Cash Flow |
Jenscare Scientific Co (HKSE:09877) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Thank you for viewing the detailed overview of Jenscare Scientific Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai Jiachen Investment Co.,ltd | 2201 Interest of corporation controlled by you | |
Li Hui | 2501 Other | |
Lv Shiwen | 2501 Other | |
Ningbo Dixiang Venture Capital Co., Ltd. | 2201 Interest of corporation controlled by you | |
Shanghai Shidi Industrial Development Co., Ltd. | 2501 Other | |
Ningbo Sangdi Investment Management L.p. (limited Partnership) | 2101 Beneficial owner | |
Ningbo Linfeng Biotechnology Co., Ltd. | 2101 Beneficial owner | |
Pan Fei | 2201 Interest of corporation controlled by you | |
Hainan Yize Medical Technology Co., Limited | 2201 Interest of corporation controlled by you | |
Hainan Maidi Enterprise Management L.p. (limited Partnership) | 2101 Beneficial owner | |
Hainan Hualing Investment L.p. (limited Partnership) | 2101 Beneficial owner | |
Hangzhou Chende Investment Partnership (limited Partnership) | 2101 Beneficial owner | |
Ningbo Mukang Venture Capital Partnership (limited Partnership) | ||
Li Hui |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.